Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-20T17:37:44.256Z Has data issue: false hasContentIssue false
  • English
  • Français

Colorectal cancer screening policy in Hungary

Published online by Cambridge University Press:  06 January 2009

László Gulácsi ,
Gábor Vas ,
István Pintér  and
Ildikó Kriszbacher
László Gulácsi
Affiliation:
Associate Professor, Department of Public Administration, Director, Health Economics and Technology Assessment Research Centre, Corvinus University of Budapest, Fővám tér 8. 1093 Budapest, Hungary ([email protected])
Gábor Vas
Affiliation:
PhD student, Department of Health-Economics, Policy & Management, University of Pécs, Vörösmarty u. 4., Pécs 7621 Hungary
István Pintér
Affiliation:
Assistant Professor, 2nd Department of Medicine, University of Pécs, Ifjúság u. 13., Pécs 7624 Hungary
Ildikó Kriszbacher
Affiliation:
Associate Professor, Institute of Nursing and Clinical Sciences, University of Pécs, Vörösmarty u. 4., Pécs 7621 Hungary
Get access Rights & Permissions [Opens in a new window]

Extract

We read with great interest the excellent paper of Gutiérrez-Ibarluzea et al. on the review of current policies of screening for colorectal cancer in European countries (12).Colorectal cancer screening has been a hot topic in health technology assessment and medical decision making (13;15;18). The study by Gutiérrez-Ibarluzea and colleagues focused mainly on the “old” fifteen member states of the European Union; however, colorectal cancer represents a large epidemiological (3;11) and economic (4) burden for the society and the healthcare financing agency in Eastern European countries. We would like to highlight some important aspect of colorectal cancer screening in Hungary.

Type
Commentaries, Views, and Developments in Hta
Information
International Journal of Technology Assessment in Health Care , Volume 25 , Issue 1 , January 2009 , pp. 109 - 110
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Boncz, I. Organized nationwide breast cancer screening programme was introduced in Hungary in 2002. Swiss Med Wkly. 2006;136:328.Google ScholarPubMed
2. Boncz, I. Prevention of cervical cancer screening in low-resource settings. JAMA. 2006;295:1248.CrossRefGoogle ScholarPubMed
3. Boncz, I, Sebestyen, A. Economy and mortality in Eastern and Western Europe between 1945–1990: The largest medical trial of history. Int J Epidemiol. 2006;35:796–797.CrossRefGoogle Scholar
4. Boncz, I, Sebestyén, A, Dávid, T. Comparative analysis of drug cost of breast, cervical and colorectal cancer in Hungary. Value Health. 2005;8:A42.CrossRefGoogle Scholar
5. Boncz, I, Sebestyen, A, Dobrossy, L, Otto, S. The role of immunochemical testing for colorectal cancer. Lancet Oncol. 2006;7:363–364.CrossRefGoogle ScholarPubMed
6. Boncz, I, Sebestyen, A, Dobrossy, L, et al. The organization and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. Ann Oncol. 2007;18:795–799.CrossRefGoogle ScholarPubMed
7. Boncz, I, Sebestyén, A, Dózsa, C, et al. Health economics analysis of colorectal screening. [In Hungarian: A colorectalis szűrések egészség-gazdaságtani elemzése] Magy Onkol. 2004;48:111–115.Google ScholarPubMed
8. Boncz, I, Sebestyen, A, Ember, I. Organized, nationwide cervical cancer screening programme in Hungary. Gynecol Oncol. 2007;106:272–273.CrossRefGoogle ScholarPubMed
9. Boncz, I, Sebestyen, A, Pinter, I, et al. Age-group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J Clin Oncol. 2007;25:4501–4502.CrossRefGoogle ScholarPubMed
10. Csonka, C, Molnár, C, Németh, M, Ottó, S. Results of and experiences with colorectal screening in town Ajka [In Hungarian: Az ajkai vastagbélszűrés eredményei és tapasztalatai] Magy Onkol. 2004;48:29.Google Scholar
11. Döbrőssy, L. Cancer mortality in central-eastern Europe: Facts behind the figures. Lancet Oncol. 2002;3:374–81.CrossRefGoogle ScholarPubMed
12. Gutiérrez-Ibarluzea, I, Asua J, Latorre K. Policies of screening for colorectal cancer in European countries. Int J Technol Assess Health Care. 2008;24:270–276.CrossRefGoogle ScholarPubMed
13. Khandker, RK, Dulski, JD, Kilpatrick, JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care. 2000;16:799–810.CrossRefGoogle ScholarPubMed
14. Kovács, A, Döbrőssy, L, Budai, A, Boncz, I, Cornides, Á. Cervical screening in Hungary: Why does the “English model” work but the “Hungarian model” does not? Eur J Gynaecol Oncol. 2008;29:5–9.Google ScholarPubMed
15. Lejeune, C, Arveux, P, Dancourt, V, Béjean, S, Bonithon-Kopp, C, Faivre, J. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer. Int J Technol Assess Health Care. 2004;20:434–439.CrossRefGoogle ScholarPubMed
16. Ottó, S, Döbrőssy, L. Screening for colorectal cancer with immunological FOBT. Br J Cancer. 2004;90:1871–1872.CrossRefGoogle ScholarPubMed
17. Ottó, S, Németh, M. Double immunochemical screening test (hemoglobin and albumin) for the detection of occult intestinal bleeding. J Clin Lab Anal. 1993;7:301–306.CrossRefGoogle ScholarPubMed
18. Villeneuve, PJ, Coombs, A. Screening for colorectal cancer using the fecal occult blood test: An actuarial assessment of the impact of a population-based screening program in Canada. Int J Technol Assess Health Care. 2003;1:715–23.CrossRefGoogle Scholar